Sankar, Kamya
Ye, Jing Christine
Li, Zihai
Zheng, Lei
Song, Wenru
Hu-Lieskovan, Siwen
Article History
Received: 3 November 2021
Accepted: 20 April 2022
First Online: 18 May 2022
Declarations
:
: Not applicable.
: Not applicable.
: KS does not have any competing interests to declare. JCY declares research funding from Janssen, GSK, Nektar, Celgene, Takeda, Karyopharm, Sanofi, CARsgen, Regeneron. WS is full time employee of Kira Pharmaceuticals. SH-L is a paid scientific advisor to Amgen, BMS, Regeneron, Genmab, Xencor, Merck, Astellas.